Table 1 Basic information of the included patients undergoing MHD according to the HAMD scores.

From: The impact of depression on platelet activation, cardiocerebral vascular events and arteriovenous fistula dysfunction in patients undergoing haemodialysis

Variable

All patients (n = 286)

NDP group (n = 183)

DP group (n = 103)

t/z/χ2

p-value

Age (y)

57.64 ± 14.44

56.83 ± 14.29

59.09 ± 14.65

−1.27

0.205a

Male (%)

122 (43)

76 (42)

46 (45)

0.26

0.607b

BMI (Kg/m2)

22.47 ± 3.35

22.59 ± 3.47

22.25 ± 3.12

0.84

0.400a

Smoke (%)

127 (44)

79 (43)

48 (47)

0.32

0.575b

Drink (%)

102 (36)

63 (34)

39 (38)

0.34

0.560b

Time on dialysis (months)

64.55 ± 45.90

66.3 ± 46.32

61.9 ± 45.24

0.73

0.466c

With diabetes mellitus (%)

83 (29)

47 (26)

36 (35)

2.75

0.097b

With cardio-cerebrovascular disease (%)

129 (45)

68 (37)

61 (59)

12.96

0.000*

SBP (mmHg)

139.82 ± 15.25

139.45 ± 15.14

140.50 ± 15.52

−0.56

0.576a

DBP (mmHg)

75.30 ± 10.32

76.22 ± 10.62

73.65 ± 9.61

2.04

0.042a*

Antiplatelets user (%)

149 (52)

90 (49)

59 (57)

1.73

0.188b

  1. Data are shown as numbers (percentages) or \(\overline{x }\)±s.
  2. NDP non-depression (HAMD < 8); DP depression (HAMD ≥ 8); SBP systolic BP; DBP diastolic BP.
  3. *p-value < 0.05 shows a statistically significant difference. a, Independent samples t-test; b, Chi-square test; c, Mann–Whitney U test.